F Yang, J Xu, M Fu, J Ji, L Chi, G Zhai - Journal of Drug Targeting, 2020 - Taylor & Francis
Doxorubicin is still used as a first-line drug in current therapeutics for numerous types of
malignant tumours (including lymphoma, transplantable leukaemia and solid tumour) …